News

Discover latest research in drug development including updates on our collaboration with the FDA and patents for our novel image-based analysis.

Tag

Showing 0 of 100

FDA product-specific guidance recommending FIB-SEM microstructure analysis for PLGA microsphere bioequivalence demonstration

December 23, 2025

FDA PSG Recommends FIB-SEM Analysis for Microsphere Bioequivalence Demonstration

digiM patent for true density measurement from micro-CT images of pharmaceutical samples

November 26, 2025

digiM Patents Density Measurement Technology for micro-CT

November 14, 2025

digiM Launches miQ3: A Microstructure Equivalence Database

digiM patent for generative AI microstructure synthesis from exemplar pharmaceutical images

October 24, 2025

digiM Awarded Patent for Generative Microstructure Synthesis Technology

FDA renews subscription to digiM I2S microstructure analysis platform for drug product quality research

October 10, 2025

FDA Renews Subscription to digiM I2S Microstructure Analysis Platform

digiM statement on responsible use of artificial intelligence and machine learning in pharmaceutical image analysis

digiM Statement on the Use of Artificial Intelligence Technologies

Dr. Ronald Smith, Executive Advisor at digiM Solution, pharmaceutical sciences industry leader

digiM Welcomes Dr. Ron Smith as an Executive Advisor

dissoLab software interface showing dissolution simulation bench with generative AI microstructure tools

January 27, 2025

digiM Launches dissoLab Software for Dissolution Simulation from Microscopic Images

Pharmacy shelf with complex drug products supported by digiM FDA IDIQ contract for regulatory microstructure characterization

October 29, 2024

digiM Awarded FDA IDIQ Contract to Support Product Guidance Development

CMAC and University of Strathclyde logos — digiM Solution partnership for digital CMC transformation

September 2, 2024

digiM Solution Partners with CMAC to Revolutionize Digital CMC Processes

Micro-CT image showing thin wall reconstruction of spray dried dispersion particles using digiM patented technique

August 20, 2024

digiM Awarded Patent to Characterize Spray-dried Particles with Thin Walls from MicroCT Images

digiM Joins DDIC to Support Drug Delivery Research

FDA purchase order for digiM I2S image analysis software subscription for drug product quality attribute assessment

January 24, 2024

FDA Purchases Image Analysis Software for Drug Product CQAs

FDA Office of Pharmaceutical Quality award to digiM for microstructural quality attribute characterization and modeling

August 22, 2023

digiM Receives Award from the FDA Office of Pharmaceutical Quality

digiM FDA BAA award press release image for microsphere critical quality attribute study

digiM Receives FDA BAA Award to Study Microsphere CQAs

Evaluating microstructure critical quality attributes for controlled release microspheres — FDA workshop presentation

digiM Featured in FDA Workshop

Batch-scale X-ray analysis of microsphere microstructures for FDA microstructure bioequivalence study

December 13, 2019

digiM Receives FDA Contract to Study Microstructure Bioequivalence

No results found.

There are no results with this criteria. Try changing your search.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Start Your Project

DigiM 3D pharmaceutical microstructure render 33 showing high-resolution material detail